Eli Lilly Sues Generic Drug Co. Over Gemzar Patents
Pharmaceutical company Eli Lilly & Co. has targeted a generic drug company in a patent infringement suit related to its top-selling cancer treatment Gemzar....To view the full article, register now.
Already a subscriber? Click here to view full article